Professional Documents
Culture Documents
Urinary Tract Infection 2020
Urinary Tract Infection 2020
HASYIM KASIM
2020
Introduction
• Urinary tract infection (UTI) is a frequent clinical
problem confronting the physician.
• Any site in the urinary tract may be involved,
including the urethra, prostate, bladder, ureter,
kidney and perinephric space.
• Bacterial infection is most common, but fungi
(primarily yeast), chlamydia, viruses, and
parasites may be responsible in some patients.
Prevalence of UTI
Ratio
Age group % (male:female)
Neonatal 1 3:2
Preschool 2-3 1:10
School age 1-2 1:30
Reproductive age 2-5 1:50
Elderly 20-30 1:10
Pathogenesis
Bacterial infections of the UTI
• Cystitis
• Acute pyelonephritis
• Chronic pyelonephritis
• Recurrent urinary tract infections
• Asymptomatic bacteriuria
• Catheter associated UTI
Other Classification
• Complicated UTI
• Uncomplicated UTI
I. Uncomplicated urinary tract infection
Systemic Conditions
Diabetes mellitus
Papillary necrosis (e.g. analgesic nephropathy)
Immunodeficient states (including immunosuppressive
drug therapy e.g. transplant recipient)
1. Is infection present?
2. Does the patient have an upper or lower urinary
tract infection?
3. Is there an anatomic abnormality that
predispose to the development of infection?
1. Symptoms :
• Lower UTI
• Upper UTI
2. Urinalysis
•The presence of 5-10 WBC / high-power field sediment
midstream urine
3. Culture
4. Radiological evaluation
• Ultrasound
• Plain abdominal radiography
• Intravenous urography
• CT scanning
Clinical features of acute lower and
upper urinary tract infection in adult
however
Symptomatic women :
• 102 coliform organisms/ml urine plus pyuria, or
• 105 of any pathogenic organism/ml urine, or
• Any growth of a pathogenic organism from urine obtained by
suprapubic aspiration
Symptomatic men :
• 103 pathogenic organism/ml urine
Asymptomatic patients :
• 105 pathogenic organism/ml urine in two consecutive samples
Indication of Radiological evaluation
Drug of Choice:
• Nitrofurantoin
• TMP-SMX
• Quinolon (Ciprofloxacin, Levofloxacin)
Severe illness
Moderate severity
No resolution
Resolution
No resolution in 5 days
in 5 days
in 5 days
Radiologic evaluation
Treatment 14 days Oral treatment 14 days or
longer as required
Antimicrobial therapy for
uncomplicated pyelonephritis
Drug of Choice:
• Quinolon (Ciprofloxacin, Levofloxacin)
• TMP-SMX
• Amoxicillin/clavulanate
Yes No
5 Days
1. Tend to occur more than 2 weeks after completion of therapy. Response well to therapy,
2. Most likely represent infections of the bladder, occur weeks to months after
treatment of the previous infection, usually associated with a normal urinary tract
Relapse :
Estrogen substitution
Antibiotic therapy :
(oral & topical)
On demand or
Postcoital or
Longterm prophylaxis
Antibiotic therapy :
On demand or
Longterm prophylaxis
Drug regimens for long-term, low-dose prophylaxis of
recurrent urinary tract infection
Drug Dose*
Nitrofurantoin 50 mg
Trimethoprim 100 mg
Co-trimoxazole 0.24 g
Norfloxacin 200 mg
Ciprofloxacin 125 mg
Cephalexin 125 mg
( useful if renal insufficiency)
Hexamine hippurate 1 g
* Treatment is effective if taken each night, alternate nights, three times a week,
or just after intercourse
Clinical Classification of Urinary Tract Infection